Shari R. Lipner

Nov 24, 2024 | healio.com | Gabrielle Capaldo |Kristen Dowd |Shari R. Lipner

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Zoom dysmorphia is the fixation on self-perceived flaws from staring at one’s reflection in a computer screen.

Oct 9, 2024 | healio.com | Shari R. Lipner |Gabrielle Capaldo |Kristen Dowd

Read more You've successfully added Psoriasis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. NEW YORK — At the Skin of Color Update 2024 meeting, a speaker discussed how to diagnose and treat nail psoriasis and nail lichen planus in patients with skin of color.

Aug 9, 2024 | mdedge.com | Shari R. Lipner

References He A, Ti Kim T, Nguyen KD. Utilization of teledermatology services for dermatological diagnoses during the COVID-19 pandemic. Arch Dermatol Res. 2023;315:1059-1062. Lee JJ, English JC 3rd. Teledermatology: a review and update. Am J Clin Dermatol. 2018;19:253-260. Wang RH, Barbieri JS, Kovarik CL, et al. Synchronous and asynchronous teledermatology: a narrative review of strengths and limitations. J Telemed Telecare. 2022;28:533-538. Miller J, Jones E.

Aug 8, 2024 | mdedge.com | Shari R. Lipner

Telemedicine interest, which was relatively quiescent prior to the COVID-19 pandemic, has surged in popularity in the past few years.1 It can now be utilized seamlessly in dermatology practices to deliver exceptional patient care while reducing costs and travel time and offering dermatologists flexibility and improved work-life balance.

May 16, 2024 | jamanetwork.com | Avrom S. Caplan |Kaitlin Benedict |Shari R. Lipner |Dallas J. Smith

Introduction Visual inspection cannot reliably distinguish fungal rashes from nonfungal inflammatory skin conditions (eg, dermatitis, eczema).1 Misdiagnosis can lead to unnecessary antifungal use for nonfungal conditions or topical corticosteroid use for fungal rashes, potentially worsening infections.2 When rash causes are uncertain, physicians may prescribe topical antifungal-corticosteroid combination products, which are often less effective and more expensive than monotherapy for fungal...